Donald J. Trump’s victory in November’s Presidential election coincides with a pivotal moment for the U.S. cannabis reform, as efforts to reschedule the substance could significantly reshape the future of the industry, with him potentially having a say. During his campaign, Trump expressed support for rescheduling cannabis from Schedule I to Schedule III of the Controlled Substances Act, which would acknowledge its medical value and ease the business tax burden. He also supported providing banking…
